Hannah M Thompson, Dana M Omer, Sabrina Lin, Jin K Kim, Jonathan B Yuval, Floris S Verheij, Li-Xuan Qin, Marc J Gollub, Abraham Jing-Ching Wu, Meghan Lee, Sujata Patil, Aram F Hezel, Jorge E Marcet, Peter A Cataldo, Blase N Polite, Daniel O Herzig, David Liska, Samuel Oommen, Charles M Friel, Charles A Ternent, Andrew L Coveler, Steven R Hunt, Julio Garcia-Aguilar
IMPORTANCE: Assessing clinical tumor response following completion of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer is paramount to select patients for watch-and-wait treatment. OBJECTIVE: To assess organ preservation (OP) and oncologic outcomes according to clinical tumor response grade. DESIGN, SETTING, AND PARTICIPANTS: This was secondary analysis of the Organ Preservation in Patients with Rectal Adenocarcinoma trial, a phase 2, nonblinded, multicenter, randomized clinical trial...
January 2, 2024: JAMA Network Open